These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34007690)

  • 1. Combating Substandard and Counterfeit Medicines by Securing the Pharmaceutical Supply Chain: The Drug Supply Chain Security Act (DSCSA) of 2013.
    Le P; Grund L; Marwa J; Ojo W; Otts J; Arab F
    Innov Pharm; 2018; 9(2):1-11. PubMed ID: 34007690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the 2015 Drug Supply Chain Security Act.
    Brechtelsbauer ED; Pennell B; Durham M; Hertig JB; Weber RJ
    Hosp Pharm; 2016 Jun; 51(6):493-500. PubMed ID: 27354753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Last Mile: DSCSA Solution Through Blockchain Technology: Drug Tracking, Tracing, and Verification at the Last Mile of the Pharmaceutical Supply Chain with BRUINchain.
    Chien W; de Jesus J; Taylor B; Dods V; Alekseyev L; Shoda D; Shieh PB
    Blockchain Healthc Today; 2020; 3():. PubMed ID: 36777051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could the Pharmaceutical Industry Benefit from Full-Scale Adoption of Radio-Frequency Identification (RFID) Technology with New Regulations?
    Coustasse A; Kimble CA; Stanton RB; Naylor M
    Perspect Health Inf Manag; 2016; 13(Fall):1b. PubMed ID: 27843419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Decentralized Verifiable Credentials to Authenticate Authorized Trading Partners and Verify Drug Provenance.
    Ashkar GL; Patel KS; de Jesus J; Vinnakota N; Helms N; Jack W; Chien W; Taylor B
    Blockchain Healthc Today; 2021; 4():. PubMed ID: 36777488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Makes a National Pharmaceutical Track and Trace System Succeed? Lessons From Turkey.
    Parmaksiz K; Pisani E; Kok MO
    Glob Health Sci Pract; 2020 Sep; 8(3):431-441. PubMed ID: 33008856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of existing and emerging digital technologies to combat the global trade in fake medicines.
    Mackey TK; Nayyar G
    Expert Opin Drug Saf; 2017 May; 16(5):587-602. PubMed ID: 28349715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food product tracing technology capabilities and interoperability.
    Bhatt T; Zhang JJ
    J Food Sci; 2013 Dec; 78 Suppl 2():B28-33. PubMed ID: 24261586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of German official medicines control laboratories in combating counterfeit medicines].
    Wiegard A; Heuermann M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1214-1220. PubMed ID: 28948293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internet of Things Based Blockchain for Temperature Monitoring and Counterfeit Pharmaceutical Prevention.
    Singh R; Dwivedi AD; Srivastava G
    Sensors (Basel); 2020 Jul; 20(14):. PubMed ID: 32708588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials.
    Batson JS; Bempong DK; Lukulay PH; Ranieri N; Satzger RD; Verbois L
    Malar J; 2016 Feb; 15():119. PubMed ID: 26917250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention.
    Sylim P; Liu F; Marcelo A; Fontelo P
    JMIR Res Protoc; 2018 Sep; 7(9):e10163. PubMed ID: 30213780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the pharmacist in preventing distribution of counterfeit medications.
    Chambliss WG; Carroll WA; Kennedy D; Levine D; Moné MA; Ried LD; Shepherd M; Yelvigi M
    J Am Pharm Assoc (2003); 2012; 52(2):195-9. PubMed ID: 22370383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicines counterfeiting is a complex problem: a review of key challenges across the supply chain.
    Tremblay M
    Curr Drug Saf; 2013 Feb; 8(1):43-55. PubMed ID: 23656447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncology drugs in the crosshairs of pharmaceutical crime.
    Venhuis BJ; Oostlander AE; Giorgio DD; Mosimann R; du Plessis I
    Lancet Oncol; 2018 Apr; 19(4):e209-e217. PubMed ID: 29611529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.